The Wolverine Blend is a combination peptide therapy that pairs BPC-157 and TB-500 in a single vial
GHRP-6 frequently asked questions How do I reconstitute a 10 mg vial of GHRP-6
Individual responses may vary, and help from medical professionals can significantly affect the safety and efficacy of these treatments
Weight loss support results can take a few weeks to become noticeable, especially when paired with consistent healthy habits.
Follow-Up & Adjustment Protocols are monitored and adjusted based on your response
Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet
